This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tang, Y. Articles by Yan, L. Search for Related Content PubMed PubMed Citation Articles by Tang, Y. Articles by Yan, L.

---

Angiogenesis, Metastasis, and the Cellular Microenvironment

Regulation of Vascular Endothelial Growth Factor Expression by EMMPRIN via the PI3K-Akt Signaling Pathway

¹ Oncology Research, ² Toxicology and Investigational Pharmacology, and ³ Molecular Biology, Centocor R&D, Inc., Malvern, Pennsylvania

Requests for reprints: Li Yan, Hematology and Oncology, Centocor R&D, Inc., 200 Great Valley Parkway, Malvern, PA 19355. Phone: 610-240-8108; Fax: 610-651-6140. E-mail: LYan2{at}cntus.jnj.com

Extracellular matrix metalloproteinase (MMP) inducer (EMMPRIN) is a cell surface glycoprotein overexpressed in many solid tumors. In addition to its ability to stimulate stromal MMP expression, tumor-associated EMMPRIN also induces vascular endothelial growth factor (VEGF) expression. To explore the underlying signaling pathways used by EMMPRIN, we studied the involvement of phosphoinositide 3-kinase (PI3K)-Akt, mitogen-activated protein kinase (MAPK), JUN, and p38 kinases in EMMPRIN-mediated VEGF regulation. Overexpression of EMMPRIN in MDA-MB-231 breast cancer cells stimulated the phosphorylation of only Akt and MAPKs but not that of JUN and p38 kinases. Conversely, inhibition of EMMPRIN expression resulted in suppressed Akt and MAPK phosphorylation. Furthermore, the PI3K-specific inhibitor LY294002 inhibited VEGF production by EMMPRIN-overexpressing cells in a dose- and time-dependent manner. On the other hand, the MAPK inhibitor U0126 did not affect VEGF production. In vivo, EMMPRIN-overexpressing tumors with elevated VEGF expression had a high level of phosphorylation of Akt and MAPK. Finally, when fibroblast cells were treated with recombinant EMMPRIN, Akt kinase but not MAPK was phosphorylated concomitant with an increase in VEGF production. Both the activation of Akt kinase and the induction of VEGF were specifically inhibited with a neutralizing antibody to EMMPRIN. Our results show that in both tumor and fibroblast cells EMMPRIN regulates VEGF production via the PI3K-Akt pathway but not via the MAPK, JUN, or p38 kinase pathways. (Mol Cancer Res 2006;4(6):371–8)

This article has been cited by other articles:

				D. Generali, S. B. Fox, M. P. Brizzi, G. Allevi, S. Bonardi, S. Aguggini, M. Milani, A. Bersiga, L. Campo, R. Dionisio, et al. Down-Regulation of Phosphatidylinositol 3'-Kinase/AKT/Molecular Target of Rapamycin Metabolic Pathway by Primary Letrozole-Based Therapy in Human Breast Cancer Clin. Cancer Res., May 1, 2008; 14(9): 2673 - 2680. [Abstract] [Full Text] [PDF]

				S. Ruiz, A. Castro-Castro, and X. R. Bustelo CD147 Inhibits the Nuclear Factor of Activated T-cells by Impairing Vav1 and Rac1 Downstream Signaling J. Biol. Chem., February 29, 2008; 283(9): 5554 - 5566. [Abstract] [Full Text] [PDF]

				F. Besse, S. Mertel, R. J. Kittel, C. Wichmann, T. M. Rasse, S. J. Sigrist, and A. Ephrussi The Ig cell adhesion molecule Basigin controls compartmentalization and vesicle release at Drosophila melanogaster synapses J. Cell Biol., June 21, 2007; 177(5): 843 - 855. [Abstract] [Full Text] [PDF]

				Z. Mi, T. Oliver, H. Guo, C. Gao, and P. C. Kuo Thrombin-Cleaved COOH-Terminal Osteopontin Peptide Binds with Cyclophilin C to CD147 in Murine Breast Cancer Cells Cancer Res., May 1, 2007; 67(9): 4088 - 4097. [Abstract] [Full Text] [PDF]